• This record comes from PubMed

A report of nonexistence of the non-Helicobacter pylori Helicobacter species in Iranian patients suffering from inflammatory bowel disease

. 2021 Oct ; 66 (5) : 751-759. [epub] 20210608

Language English Country United States Media print-electronic

Document type Journal Article

Grant support
RIGLD 995 Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Links

PubMed 34101130
DOI 10.1007/s12223-021-00883-z
PII: 10.1007/s12223-021-00883-z
Knihovny.cz E-resources

Inflammatory bowel disease is a chronic, relapsing-remitting gastrointestinal disorder which has become a serious global concern, and it imposes a great degree of health and economic burdens on communities worldwide. Although the presence of non-Helicobacter pylori Helicobacter (NHPH) microorganisms has been reported in various gastrointestinal disorders, their putative role in the pathogenesis of IBD has been a matter of controversy. The present study aimed to investigate the existence of gastric and enterohepatic NHPHs and their probable coinfection with H. pylori in IBD. Totally, 168 clinical specimens including 70 colonic biopsies and 98 fecal specimens were obtained from IBD patients. Genomic DNA was extracted from all samples, and its quality and concentration were assessed by β-globin PCR and spectrophotometry. The Helicobacter genus-specific PCR was performed using 16S rRNA gene. All samples were also tested for H. pylori infection by PCR of ureC gene fragment (glmM). The presence of NHPH was examined by using species-specific PCR assays. Based on PCR results, H. pylori was detected in 12.9% and 3.1% of colonic biopsies and fecal specimens, respectively. However, no statistically significant correlation was observed (P value > 0.05). We failed to find NHPH in both colonic biopsies and fecal specimens from IBD patients. Despite the fact that none of the IBD patients harbored the NHPH in the current work, further cohorts with larger sample size are required to determine the possible relationship between NHPH infection and IBD pathogenesis.

See more in PubMed

Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5:17–30 DOI

Amorim I, Smet A, Alves O, Teixeira S, Saraiva AL, Taulescu M, Reis C, Haesebrouck F, Gärtner F (2015) Presence and significance of Helicobacter spp. in the gastric mucosa of Portuguese dogs. Gut Pathog 7:12

Arnold IC, Hitzler I, Müller A (2012) The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol 2:10 PubMed DOI PMC

Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA (2003) Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 18:481–486 PubMed DOI

Bohr URM, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P (2004) Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 42:2766–2768 PubMed DOI PMC

Bohr URM, Kuester D, Meyer F, Wex T, Stillert M, Csepregi A, Lippert H, Roessner A, Malfertheiner P (2007) Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. Clin Microbiol Infect 13:525–531 PubMed DOI

Burisch J, Jess T (2019) Does eradication of Helicobacter pylori cause inflammatory bowel disease? Clin Gastroenterol Hepatol 17:1940–1941 PubMed DOI

Cao DM, Lu QF, Li SB, Wang JP, Chen YL, Huang YQ, Bi HK (2016) Comparative genomics of H. pylori and non-pylori Helicobacter species to identify new regions associated with its pathogenicity and adaptability. BioMed Res Int 2016:6106029

Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM (2017) Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 66(2):235–249 PubMed DOI

De Groote D, Van Doorn LJ, Van den Bulck K, Vandamme P, Vieth M, Stolte M, Debongnie JC, Burette A, Haesebrouck F, Ducatelle R (2005) Detection of non-pylori Helicobacter species in “Helicobacter heilmannii”-infected humans. Helicobacter 10:398–406 PubMed DOI

Farzi N, Yadegar A, Sadeghi A, Asadzadeh Aghdaei H, Marian Smith S, Raymond J, Suzuki H, Zali MR (2019) High prevalence of antibiotic resistance in Iranian Helicobacter pylori Isolates: importance of functional and mutational analysis of resistance genes and virulence genotyping. J Clinical Med 8(11):2004

Foltz CJ, Fox GJ, Cahill R, Murphy JC, Yan L, Shames B, Schauer DB (1998) Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3:69–78 PubMed DOI

Fox JG, Shen Z, Xu S, Feng Y, Dangler CA, Dewhirst FE, Paster BJ, Cullen JM (2002) Helicobacter marmotae sp. nov. isolated from livers of woodchucks and intestines of cats. J Clin Microbiol 40:2513–2519 PubMed DOI PMC

Fox JG (2002) The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50:273–283 PubMed DOI PMC

García A, Xu S, Dewhirst FE, Nambiar PR, Fox JG (2006) Enterohepatic Helicobacter species isolated from the ileum, liver and colon of a baboon with pancreatic islet amyloidosis. J Med Microbiol 55:1591–1595 PubMed DOI

Genta RM, Sonnenberg A (2015) Helicobacter-negative gastritis: a distinct entity unrelated to Helicobacter pylori infection. Aliment Pharmacol Ther 41:218–226 PubMed DOI

Genta RM, Sonnenberg A (2012) Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 35:1310–1316 PubMed DOI

Germani Y, Dauga C, Duval P, Huerre M, Levy M, Pialoux G, Sansonetti P, Grimont PAD (1997) Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol 148:315–326 PubMed DOI

Goto K, Ohashi H, Takakura A, Itoh T (2000) Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr Microbiol 41:161–166 PubMed DOI

Greer CE, Wheeler CM, Manos MM (1994) Sample preparation and PCR amplification from paraffin-embedded. Genome Res 3:S113–S122 DOI

Grehan M, Danon S, Lee A, Daskalopoulos G, Mitchell H (2004) Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J Clin Microbiol 42:874–876 PubMed DOI PMC

Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Medical Microbiol 61:1–14 DOI

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterol 153:420–429 DOI

Kauser F, Hussain MA, Ahmed I, Ahmad N, Habeeb A, Khan AA, Ahmed N (2005) Comparing genomes of Helicobacter pylori strains from the high-altitude desert of Ladakh, India. J Clin Microbiol 43:1538–1545 PubMed DOI PMC

Laharie DCA, Asselineau J, Bulois P, Bourreille A, Moreau J, Bonjean P, Lamarque D, Pariente A, Soulé JC (2009) Association between entero-hepatic Helicobacter species and Crohn’s disease: a prospective cross-sectional study. Aliment Pharmacol Ther 30:283–293 PubMed DOI

Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JY, Sung JJ, Ding C (2009) Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PloS One 4:e7985

Lo Presti A, Zorzi F, Del Chierico F, Altomare A, Cocca S, Avola A, De Biasio F, Russo A, Cella E, Reddel S (2019) Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease. Front Microbiol 10:1655 PubMed DOI PMC

M’Koma AE (2014) Diagnosis of inflammatory bowel disease: potential role of molecular biometrics. World J Gastro Surg 6:208 DOI

Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani M, B, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL, (2005) Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a−/−mice results in colitis that progresses to dysplasia. Amer J Pathology 166:1793–1806 DOI

Man SM, Zhang L, Day AS, Leach S, Mitchell H (2008) Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn’s disease. Helicobacter 13:234–238 PubMed DOI

Murase K (2016) Gastritis with distinctive histopathology (non-Helicobacter pylori gastritis ). Acta Med Nagasaki 46:9–14

O’rourke JL, Grehan M, Lee A, (2001) Non-pylori Helicobacter species in humans. Gut 49:601–606 DOI

Øverby A, Murayama SY, Michimae H, Suzuki H, Suzuki M, Serizawa H, Tamura R, Nakamura S, Takahashi S, Nakamura M (2017) Prevalence of gastric non-Helicobacter pylori-Helicobacters in Japanese patients with gastric disease. Digestion 95:61–66 PubMed DOI

Papamichael K, Konstantopoulos P, Mantzaris GJ (2014) Helicobacter pylori infection and inflammatory bowel disease: is there a link? World J Gastroenterol 20:6374 PubMed DOI PMC

Peng X, Zhou L, Gong Y, Song Z, He L, Lin S, Zhang J (2017) Non-pylori Helicobacters (NHPHs) induce shifts in gastric microbiota in Helicobacter pylori-infected patients. Front Microbiol 8:1038 PubMed DOI PMC

Peura DA, Haber MM, Hunt B, Atkinson S (2010) Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol 44:180–185 PubMed DOI

Powers-Fletcher MV, Couturier MR (2015) Non-Helicobacter pylori Helicobacter species associated with human disease: a primer for the clinical microbiology laboratory. Clin Microbiology Newsl 37:93–101 DOI

Rimbara E, Mori S, Kim H, Matsui M, Suzuki S, Takahashi S, Yamamoto S, Mukai M, Shibayama K (2013) Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012. J Clin Microbiol 51:2439–2442 PubMed DOI PMC

Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, Magalhaes Queiroz DM, Megraud F (2005) Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54:396–401 PubMed DOI PMC

Sayar R, Shokri Shirvani J, Hajian-Tilaki K, Vosough Z, Ranaei M (2019) The negative association between inflammatory bowel disease and Helicobacter pylori seropositivity. Caspian J Intern Med 10:217–222 PubMed PMC

Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB (2017) Clinical manifestations of Helicobacter pylori-negative gastritis. Clin Gastroenterol Hepatol 15:1037-1046.e3 PubMed DOI

Shomer NH, Dangler CA, Schrenzel MD, Fox JG (1997) Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 65:4858–4864 PubMed DOI PMC

Singh P, Ananthakrishnan A, Ahuja V (2017) Pivot to Asia: inflammatory bowel disease burden. Intest Res 15:138 PubMed DOI PMC

Thomson JM, Hansen R, Berry SH, Hope ME, Murray GI, Mukhopadhya I, McLean MH, Shen Z, Fox JG, El-Omar E (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PloS One 6(2):e17184

Vafaeimanesh J, Alebouyeh M, Seyyedmajidi M, Tajeddin E, Sherafat SJ (2012) Molecular Detection of Helicobacter species and other bacteria in human bile samples of patients with biliary diseases. J Gastrointest Dig Syst 2:1 DOI

Van den Bulck K, Baele M, Hermans K, Ducatelle R, Haesebrouck R, Decostere A (2005) First report on the occurrence of ‘Helicobacter heilmannii’in the stomach of rabbits. Vet Res Commun 29:271–279 PubMed DOI

Veijola L, Nilsson I, Halme L, Al-Soud WA, Mäkinen J, Ljungh A, Rautelin H (2007) Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann Med 39:554–560 PubMed DOI

Wu XW, Ji HZ, Yang MF, Wu L, Wang FU (2015) Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol 21(15):4750–4756 PubMed DOI PMC

Yadegar A, Alebouyeh M, Lawson AJ, Mirzaei T, Nazemalhosseini Mojarad E, Zali MR (2014a) Differentiation of non-pylori Helicobacter species based on PCR-restriction fragment length polymorphism of the 23S rRNA gene. World J Microbiol Biotechnol 30:1909–1917 PubMed DOI

Yadegar A, Mohabati Mobarez A, Alebouyeh M, Mirzaei T, Kwok T, Zali MR (2014b) Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran. World J Microbiol Biotechnol 30:2481–2490 PubMed DOI

Yadegar A, Mohabati Mobarez A, Zali MR (2019) Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases. Cancer Med 8:1619–1632 PubMed DOI PMC

Yu Q, Zhang S, Li L, Xiong L, Chao K, Zhong B, Li Y, Wang H, Chen M (2015) Enterohepatic Helicobacter species as a potential causative factor in inflammatory bowel disease: a meta-analysis. Medicine 94(45):e1773

Yu Y, Zhu S, Li P, Min L, Zhang S (2018) Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 9:1–12 DOI

Zhang L, Day A, McKenzie G, Mitchell H (2006) Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol 44:2276–2279 PubMed DOI PMC

Zuo T, Ng SC (2018) The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol 9:2247 PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...